[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Edwards et al., 1974 - Google Patents

Diseases of the hypothalamus and pituitary gland

Edwards et al., 1974

Document ID
286775909488307477
Author
Edwards C
Besser G
Publication year
Publication venue
Clinics in Endocrinology and Metabolism

External Links

Snippet

In this chapter the basic investigations necessary to diagnose and treat gigantism and acromegaly, hypopituitarism (including pituitary dwarfism), galactorrhoea and diseases of the posterior pituitary are described. The investigation of Cushing's syndrome due to …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2221—Relaxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2278—Vasoactive intestinal peptide [VIP]; Related peptides (e.g. Exendin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Similar Documents

Publication Publication Date Title
Henneman et al. Effects of human growth hormone in man
Ottesen et al. Penile erection: possible role for vasoactive intestinal polypeptide as a neurotransmitter.
Mortimer et al. Interaction between secretion of the gonadotrophins, prolactin, growth hormone, thyrotrophin and corticosteroids in man: the effects of LH/FSH‐RH, TRH and hypoglycaemia alone and in combination
LACHELIN et al. Functional delineation of hyperprolactinemic-amenorrhea
Enomoto et al. Cardiovascular and hormonal effects of subcutaneous administration of ghrelin, a novel growth hormone-releasing peptide, in healthy humans
RABKIN et al. Hypopituitarism: a study of growth hormone and other endocrine functions
Jenkins et al. Hypothalamic-pituitary function in patients with craniopharyngiomas
KAPTEIN et al. Effects of prolonged dopamine infusion on anterior pituitary function in normal males
SAMAAN et al. Serum growth hormone and prolactin response to thyrotropin-releasing hormone in patients with acromegaly before and after surgery
Morley et al. Galactorrhea and hyperprolactinemia associated with chest wall injury
Insler et al. Polycystic ovarian disease: a challenge and controversy
Patel et al. Peripartum hypopituitarism and lymphocytic hypophysitis
Abboud et al. Clinical endocrinological approach to hypothalamic-pituitary disease
Edwards et al. Diseases of the hypothalamus and pituitary gland
Del Pozo et al. Prolactin: I. Mechanisms of Control, Peripheral Actions and Modification by Drugs
Kenny et al. Iatrogenic hypopituitarism in craniopharyngioma: Unexplained catch-up growth in three children
Dizerega et al. Diagnosis of Sheehan's syndrome using a sequential pituitary stimulation test
Schaison et al. Critical study of the growth hormone response to dynamic tests and the insulin growth factor assay in acromegaly after microsurgery
Malarkey et al. Long-term assessment of patients with macroprolactinemia
Glasier et al. Induction of ovarian activity by pulsatile infusion of LHRH in women with lactational amenorrhoea
KLETZKY et al. A sequential pituitary stimulation test in normal subjects and in patients with amenorrhea-galactorrhea with pituitary tumors
Piaditis et al. Dysfunction of the growth hormone/insulin‐like growth factor‐I axis in women with polycystic ovarian syndrome
Woolf et al. Hypoglycemia as a provocative test of prolactin release
Word et al. The effect of gonadotropin-releasing hormone agonists on growth hormone secretion in adult premenopausal women
Patton et al. The effect of deglycosylated human chorionic gonadotropin on corpora luteal function in healthy women